Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth

Xue, YH; Jiang, KQ; Ou, L; Shen, MJ; Yang, Y; Lu, JJ; Xu, WH

Xu, WH (通讯作者)，Soochow Univ, Affiliated Hosp 2, Dept Thorac Surg, Suzhou, Peoples R China.;Lu, JJ (通讯作者)，Jiangsu Univ, Affiliated Kunshan Hosp, Dept Radiotherapy & Oncol, Kunshan, Peoples R China.

CELL DEATH & DISEASE, 2022; 13 (7):

Abstract

Sphingosine kinase 1 (SphK1) and sphingosine kinase (SphK2) are both important therapeutic targets of non-small cell lung cancer (NSCLC). SKI-349 is a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索